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Background: The emerging disease outbreaks and pandemics affect immunization 
activities. In Africa, it has contributed to a significant decline in vaccination coverage and 
the provision of essential health services.  The contributing factors which affect the 
immunization activities are unclear and vary as per the country's situation and response 
strategy to the emerging outbreaks and pandemics. Hence, we aimed to explore those 
factors related to disease outbreak, epidemic, and covid-19 pandemic affecting the delivery 
of immunization services in Africa.  
Methods: Our study is qualitative exploratory research, which included five countries 
selected using convenience sampling according to the regional classification of Africa by 
ACDC.  Factors affecting routine immunization activities in the countries were identified 
through interviews with relevant stakeholders involved in vaccination services. The 
interviewees were selected using snowballing sampling, 4 participants from each country, 
twenty key informants ranking (routine immunization directors, national immunization 
officers, EPI officers, and some health workers and caregivers) were included for open-
ended and semi-structured virtual in-depth interviews. Additionally, some parents were 
interviewed for their perceptions about vaccinating their children during the current 
pandemic. We also did a literature review on the impact of previous emerging disease 
outbreaks on routine immunization activities in the countries and the current situation of 
the COVID-19 pandemic. Supportive trend data based on measles vaccination coverage 
and disease rates based on WHO country reports over time were included. Data generated 
from the literature review and in-depth interviews were transcribed verbatim and analyzed 
using thematic analysis. We used the thematic framework to organize our findings; each 
country was identified according to the following variables: Country name, the current 
situation of covid-19, covid-19 impact on the following factors (health system, governance, 
and community), and the impact of a previous disease outbreak on the measles 
vi 
 
immunization coverage.  Findings were grouped according to the country's perspective. We 
compared factors during previous outbreaks and covid-19 pandemics in Africa and 
addressed some interventions that can support immunization activities during disease x 
outbreak. 
Results: 40% of our participants emphasized that fear of infection was behind the 
interruption in the immunization activities during covid-19 pandemics. 35% agreed that 
movement restrictions limited many activities. Resource limitation and misinformation 
comes as an individual barrier representing 10-15%. Some of the addressed health system 
factors included: surveillance defect, human resource shortage, lack of training, 
infrastructure, and PPE inadequacy. On the community base: misinformation, vaccine 
hesitancy and refusal, and fear of infection were identified. Governance factors included: 
movement restriction, travel ban, closed health facilities, lockdown, and social distancing 
factors were addressed. Few gaps were identified, as providing the proper training to the 
health workers and the caregivers, community engagement, national planning, building a 
proper registry system with implementing the proper plans for fast service recovery after a 
pandemic. By fulfilling those gaps, we may be able to provide better access to routine 
immunization during a disease outbreak, epidemic, and pandemic.  
Conclusions: The study addressed the various factors affecting Africa’s routine 
immunization activities during disease outbreaks and pandemics. It also addressed the 
impact of a previous disease outbreak on the measles immunization coverage, which may 
predict the covid-19 impact on the immunization coverage. It is, therefore, essential for 
decision-makers to address those factors to ensure immunization coverage without any 
missed opportunities. 
Keywords: vaccination, outbreaks, covid-19, factors, Africa, misinformation, hesitancy.




1.1  BACKGROUND  
 
Vaccines save lives! for a safer, more secure world from global health threats posed 
by infectious diseases, vaccination has been part of the public health response to 
the emergence of future pandemic illness. Aside from the Global Health Security 
Agenda (GHSA) action package, immunization has made a remarkable 
contribution to public health across the world, but more so in Africa. It assisted in 
the control, elimination, and eradication of life-threatening diseases. 
 
In May 2012, WHO set a Global Action Plan for vaccination (GVAP) that has been 
endorsed by 194-member states of the World health assembly (WHA) to achieve 
equitable access to existing vaccines for people in all communities. However, 
immunization activities have met with many challenges to achieve the expected 
target for universal coverage. [1] 
 
Not to mention that mass immunization campaigns, clinical trials, and other 
research also face barriers to achieve their targets. Moreover, vaccine hesitancy is 
a real issue in Africa because of limited data availability. In this study, we tried to 
understand challenges with the immunization activities in Africa with an in-depth 
focus on the impact of the outbreak, epidemic, and pandemic on the routine 
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1.2  LITERATURE REVIEW: 
 
WHO and UNICEF endorsed The Global Vaccine Action Plan (GVAP) 2011-2020 
as a Global and Regional agenda with the vision of communities free of VPD 
(vaccine-preventable diseases, including diphtheria, neonatal tetanus measles, 
pertussis, and poliomyelitis) [3]. The GVAP target was to achieve 90% national 
vaccination coverage and 80% coverage in every district or equal unit for all 
vaccines in national immunization programs. [4] In parallel, The WHO Regional 
Committee recognized the Regional Strategic Plan for Immunization (RSPI) 2014-
2020 during its 64th session with comparable objectives to the GVAP [5] seeking 
90% national vaccination coverage and 90% of Diphtheria-Tetanus-Pertussis 
(DTP3) immunization in 80% of the neighborhoods. [4] It included Multi-Year 
Plans (CMYP) for firming up the national immunization systems to attain proper 
vaccination in the region. 
 
Since 2000, the measles mortality has declined by 88% in the African Region, 
where 70% coverage for three doses of the diphtheria-tetanus-pertussis (DTP3) 
vaccine and the first dose of the measles vaccine has been achieved. However, the 
region is still struggling to eradicate the VPD morbidity, and mortality causes. [6]  
It is vital to observe the national coverage of routine immunization in Africa in 
recognition of the new vaccine introduction requirements, capacity development, 
data, and immunization coverage estimates. [7] Despite the progress in achieving 
the millennium development goals (MDGs), Africa is limited in achieving the 
sustainable Goal (SDGs) related to health and still far from achieving the GVAP 
targets because of the immunization programs’ challenges. [8] [9] One of the 
biggest challenges that limit achieving the immunization coverage targets in Africa 
is the impact of disease outbreaks, epidemics, and pandemics through many 
factors.  
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Africa has been affected by many disease outbreaks, only in 2018, 36 African 
countries reported 96 disease outbreaks to the WHO African region. An elevated 
number of Measles cases have been observed during the 2013-2016 Ebola outbreak 
in Africa. The Ebola outbreak affected the measles immunization coverage in the 
region when most of the resources were allocated to support the Ebola response. 
The Ebola response strategy affected the immunization coverage lead to measles 
outbreaks and other vaccine-preventable diseases at that time.  
 
On 30th January 2020, WHO declared the new Coronavirus (COVID-19) as 
PHEIC, the new Pandemic (caused by the novel SARS-Cov-2 virus), which has 
since drawn global attention and response. As of 13th October 2020, this global 
pandemic infected 38M cumulative cases, 26.4M were recovered, and 1.08M death 
was recorded worldwide. Almost all the African countries were affected by the 
pandemic, recording 1.5M cumulative cases, 1.3M recoveries, and 38K death. 
South Africa was the most affected African country with more than 693K 
Cumulative cases by the same date. Routine Immunization Activities are at risk of 
disruption due to the severe health system breakdown, the country lockdown, and 
the social distancing measures that have been taken in place to mitigate the 
COVID-19 pandemic. The same impact of Ebola is predicted to happen on the 








- 4 - 
 
Outbreaks, epidemics, and pandemics disrupt the immunization activities in Africa 
through many factors not limited to: 
 
Fig.1.1: Framework of the contributing factors which affect the routine 
immunization activities in Africa. 
 
1.2.1  Health system factors  
i. Service delivery 
In 2014, the Ebola virus disease (EVD) outbreak in West Africa reported 
28,616 cases and 11,310 deaths in Guinea, Liberia, and Sierra Leone on 28th 
March 2016. [10] This outbreak was identified as the most massive and most 
persistent Ebola outbreak in history. It was declared a public health emergency 
of international concern (PHEC) by the WHO on 8th August 2014, under the 
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EVD outbreak disrupted health care systems in the area, weakened the local 
health care system and the vaccine service delivery, and increased the number 
of susceptible children, leading to more deaths from vaccine preventive disease 
(VPD) than from EVD. [11]  
ii. Surveillance 
It is difficult to access the database and conduct surveillance during a disease 
outbreak without facing political, bureaucratic barriers. [12] The broken 
healthcare systems and community-based surveillance defect affect the 
surveillance systems of any kind. The basic health indicators (death rates, 
causes of death, or burden of disease), the surveillance for specific 
communicable and vaccine-preventable diseases face many challenges during 
a disease outbreak.  
After 52 days of Zero reported Ebola cases by the country, the Ebola virus 
disease in the Democratic Republic of Congo is still active, as of 13th April 
2020; the health authorities Reported two new confirmed cases of (EVD) in 
Beni. The unpredicted outbreak was raised after a formal declaration of the end 
of the outbreak was announced.  that outbreak disturbs the surveillance system 
and the public health response measures in the country. [13] Although the 
immunization coverage was low before the EVD, it dropped further during the 
outbreak. Most Ebola-affected counties showed a higher decline than the least-
affected ones. There was also a decline in the monthly reports received during 
the outbreak. [14]  
iii. Human resources 
During the EVD outbreak in Liberia, all planned national immunization 
campaigns were postponed. Due to human resource limitations, HCWs were 
not able to extend immunization through outreach services.[14] Meanwhile, 
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the fear of contracting EVD from the health care facilities prevented caregivers 
from pursuing immunization services for their children. Therefore the number 
of immunized children from all antigens decreased by almost 50% during this 
period in Liberia.[14]  
iv. Logistics and Infrastructure: 
In the twenty-first century, the WHO declared the first influenza Pandemic in 
2009.[15] The 2009 pandemic of influenza A virus subtype H1N1 (A[H1N1] 
pdm09) infection spread quickly via human-to-human transmission to produce 
substantial morbidity and mortality worldwide was estimated that Africa had 
experienced the highest mortality. At that time, WHO supported the 
distribution of 900 million doses of the Pandemic influenza vaccine in low- 
and middle-income countries as a global response to the 2009 influenza. 
Unlike the developed countries, the vaccine introduction in Africa was affected 
by delays in the procurement, delivery, administration, and coverage due to 
logistical and infrastructure defects. [16]  
 
Managing the cold chain equipment in areas where electricity is not available 
limits the introduction of multiple new vaccines in Africa. [17] Likewise, 
service delivery including supply chain, distribution, and transportation. [18, 
19] Vaccine stock-out impairment [20] contributes to these issues especially 
when the country is reallocating all its resources to fight against a disease 
outbreak. An average of 38% of stock-out events was recorded from 2011- 
2015 in the Sub-Saharan Africa region[21]. The causes of these stock out 
events were primarily due to funding or procurement delays, management, and 
forecasting issues on the national level according to the WHO/UNICEF Joint 
Reporting Form (JRF) mechanism report in 2016 [22].  In-adequate 
infrastructure affected the immunization coverage in Africa for a long in 
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parallel to the limitation of the trained health care personnel with the distracted 
registration and administrative system.[23] [24] 
1.2.2  Community factors 
Socio-behavioral insights 
i. Vaccine hesitancy 
Vaccine refusal has been associated with outbreaks of many diseases in many 
African countries. While not much data is available, refusal to vaccinate has 
been witnessed in Africa. An increasing number of African citizens are 
delaying or refusing vaccination, although safe and effective vaccines are 
accessible. This Leads to deadly outbreaks of infectious diseases, which 
consumes resources and costs lives. Vaccine hesitancy is of global concern; 
however, we still are facing several knowledge gaps, mostly in Africa. Most 
of the researches on this topic has been conducted in high-income countries. 
Therefore, the knowledge about the nature and causes of vaccine hesitancy in 
the African countries is limited, with no evidence-based interventions.  
 
On the other hand, the World Health Organization recognizes vaccine 
hesitancy as a priority issue requiring global attention. [25] Vaccine hesitancy 
is multifactorial and country-specific. [26] Unlike the high-income countries. 
Developing countries are facing different vaccine challenges. where vaccine 
hesitancy poses a complex interplay of structural and psychological influences. 
[27] WHO proposed the drivers of vaccine hesitancy as (5C model) 
confidence, complacency, convenience, risk calculation, and collective 
responsibility, based on research lead by WEIRD (Western, Educated, 
Industrialized, Rich, and Democratic) societies. [26, 28] [29] Parents play an 
essential role and sometimes can be barriers to their children's immunization. 
Vaccination schedules confusion, financial burden, culture, religious 
obstructions, and fear are some of the challenges facing children immunization 
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[30]. The hesitancy about vaccine effectiveness in comparison to natural 
disease immunity still exists [31]. Many parents believe that too many 
vaccinations may weaken the immune system or affect future disease 
incidence, and this also contributed to their vaccination hesitancy. [32] 
Community and media also influence vaccine confidence and acceptance in 
negative ways. News fabrication and sketchy reports of so-called vaccine 
reactions and anti-vaccination campaigns influence the parents and increase 
the hesitancy about vaccination [33] [34] 
ii. Misinformation  
Rumors, misinformation widely affected African society during the covid-19 
pandemic. People do not trust their governments, and the source of their 
information is not accredited. During the recent covid-19 pandemic, rumors 
have been escalated that Africans would be used as clinical trials for the covid-
19 vaccine. That misinformation affected people's perception of routine 
vaccination. Parents were afraid that their children might get injecting with 
dangerous vaccines instead of the safe and proven ones. People who are 
responsible for that misinformation used various channels to spread the 
rumors. For instants, in Senegal, many posts were shared on social media and 
Facebook that 7 children died after being vaccinated by the COVID-19 
vaccine. Those posts were shared thousands of times within the society in both 
French and English.    
iii. Mass gathering 
2019 was a year of outbreaks in Africa, started by a Measles outbreak in 
Madagascar, Democratic Republic of Congo (DRC), Chad, Nigeria. Every 2-
3 years, DRC suffers from a measles outbreak, but 2019 was the highest. 
reaching a peak of 311,471 reported cases compared by records 88,381 cases 
in 2013 – 133,802 in 2011 – 182,485 in 2005).[35] Mass gatherings were 
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behind the high transmission of measles, as reported that there were youth 
sports competitions, music festivals, and religious meetings. High population 
density, high birth rate, and poor access to vaccination, aligned with a high 
incidence of epidemics in Africa, pose a challenge to immunization coverage. 
Responsive vaccination campaigns appear to have been mostly responsible for 
the decline in the incidence of the measles outbreak in the Central Africa 
Republic, which is to be, commended in the face of continuing insecurity with 
the COVID-19 pandemic. There is, however, no room for complacency in a 
country with generally low routine vaccination coverage. [36] 
 
1.2.3 Governance factors 
i. Outbreak response measures 
Following the WHO recommendations in responding to covid-19, each of the 
affected countries initiated a range of measures to mitigate the transmission of 
covid-19 and decrease healthcare systems’ impact. Countries have 
implemented a travel ban, social distancing, temporary lockdown, and 
movement restriction measures to curb the spread of infection and minimize 
the virus’s impact.  
In structuring these measures, with the interruption of the immunization 
services, there will be a risk of morbidity and mortality from vaccine-
preventable diseases (VPDs), impacting the global burden of disease. The 
delay of immunization services, even for short periods, may result in a higher 
risk of outbreaks (VPD-related deaths and increased burden on health systems 
that already overwrought by the COVID-19 response. 
Moreover, on March 24th, 2020, the Global Polio Eradication Initiative 
(GPEI’s) leadership called on all countries to postpone their mass campaigns 
and boost immunity to polio until at least the second half of this year. The 
targeted campaigns underway in Africa not only as a protective measure 
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against covid-19 but also to stop outbreaks sparked by the live virus vaccine 
itself where cases were reported in several African countries.  As of April 1st, 
2020, the world health organization reported two circulating vaccine-derived 
poliovirus cVDPV2 cases in the Democratic Republic of the Congo (DR 
Congo) – and five cVDPV2 cases in Ethiopia with five cVDPV2 cases in 
Ghana in a total of 12 new cases of the virus. By September, there are 50 cases 
reported in 2020, while the 2019 case count remains 88. [37] If under-
immunized population defecated vaccine-virus still circulate for a period. The 
virus survives as the genetic mutation undergoes. On infrequent occasions, the 
vaccine-virus can genetically mutate into a form that causes the disease – this 
is what is known as a circulating vaccine-derived poliovirus (cVDPV). [38] 
ii. Funding, financing, and commitment  
Ministers, WHO, and the private sector have an essential role in increasing 
vaccine accessibility by commitment, robust delivery schemes, and improved 
data gathering to delivering the vaccine to each child in Africa.  [39] As per 
2011–2020 estimates, investing in the vaccine is a cost-effective intervention, 
where every paid dollar for vaccination would result in the return of 16 times 
of the costs, compared to the cost for treatment and productivity losses.  
Researchers estimated that the cost of fully vaccinating a child in the Region 
is at the $25–$45 range [40] [41] [42], not including service delivery, training, 
monitoring, evaluating, and tracking outbreaks. It was estimated that between 
2016 and 2020, Africa would require $17 billion for vaccines and vaccination 
service delivery, where Governments were expected to support $6 billion and 
$6 billion coming from donors with a gap of $5 billion. Currently, Gavi 
supports most of the countries in Africa to implement their national 
immunization programs. Some countries allocated a budget for vaccination in 
their national plans but unfortunately did not utilize them to the expected 
degree. [2] Governments should invest more in immunization programs as the 
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low and middle-income gross domestic product increases, and their eligibility 
for donor funds for immunization decreases. 
 
While the world attention focuses on the new Covid-19 pandemic on 24th 
January 2020, the Central African Republic Ministry of Health declared a 
national epidemic of measles. Over 3,600 cases were recorded, and 53 deaths 
were reported between February 2019 and January 2020. This made the 
authorities call for technical partners and the donor's support to immediately 
respond to this outbreak and secure enough vaccines, targeting all children 
aged between 6 months and nine years old. This was a mission that would be 
impossible with the lockdown measures and the travel panes taken by most 
countries worldwide. [36] 
 
In parallel, on 25th January 2020, a new outbreak of Lassa fever was declared 
in Nigeria.  Through its Centre for Disease Control (NCDC), Nigeria activated 
its national emergency operations center (EOC) in collaboration with national 
and international partners to the Lassa fever outbreak across different areas of 
the country. 195 confirmed cases and 29 deaths were recorded from 1st to 24th 
January alone across 11 states.  Lassa fever is endemic in Nigeria, where the 
number of cases usually increases during the dry season in January due to 
weather conditions. Nevertheless, with the current situation and the country 
lockdown during the Covid-19 pandemic, shortages of critical treatment and 










1.3    STUDY GOAL 
To understand the factors affecting the immunization activities in 5 
convenience selected African countries during the recent covid-19 
pandemic.  
 
1.4  STUDY OBJECTIVES 
To indicate the factors affecting the routine immunization activities 
during disease outbreaks, epidemics, and pandemics.   
 
1.5 STUDY QUESTION  
What are the factors affecting immunization activities during various 
epidemics in Africa?  
 
1.6   HYPOTHESIS 
An outbreak, epidemic, and pandemic pose a barrier to immunization 











2.1  STUDY DESIGN 
This research type is a qualitative exploratory study that provides comparative 
information within and across countries on the impact of outbreaks and epidemics 
on routine immunization rates. It includes a detailed examination of the (health 
system, governance, and community) factors associated with responses to the 
covid 19. The study involves in-depth interviews and responses to a questionnaire 
with key informants to understand the challenges and impact of various outbreaks, 
epidemics, and the covid 19 pandemic on the country’s routine immunization 
services within five selected African countries.  We also did a literature review on 
the impact of previous emerging disease outbreaks on the routine immunization 
activities and the current situation of the covid-19 pandemic. This study’s ethical 
approval was received from Yonsei University Health System, Institutional 
Review Board on 24th August 2020 with IRB approval number: Y-2020-0108. 
 
2.2  UNIT OF ANALYSIS (COUNTRY) 
Using convenience sampling, we selected 1 
country from each region of Africa 5 countries 
according to the ACDC regional classification of 
Africa to compare our findings. The Countries 
are Nigeria (West), Democratic Republic of 
Congo (Central), Uganda (East), Egypt (North), 




Fig 2.1 The selected countries 
representing the 5 African 
regions. 
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2.3 DATA COLLECTION 
 
Data collection took place from 24th August ~ 30th October 2020. 
 
Using: Open-ended and semi-structured in-depth virtual interview questions (IDIs) 
with 20 participants working on different immunization activities in the 5 randomly 
selected countries. The interviews were conducted online using the WebEx 
meeting program. The same interview guide was used for all participants to 
identify variations. 
 
The interview questions were set in categories, translated into (French, Arabic) and 
sent as a questionnaire to some participants in DRC and Egypt (due to language 
barrier). We received their answer by email. Follow up questions were sent to them 
for more in-depth answers. Additionally, some parents were questioned about their 
perceptions about vaccinating their children during the current pandemic. 
 
Supportive trend data based on vaccination coverage and disease rates based on 
WHO country reports over time were included. Other supporting data were 
collected from WHO, UNICEF, GAVI Reports, UNDP, Vaccine confident project, 
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2.4 INTERVIEW PARTICIPANTS AND SAMPLING 
Using Snowball sampling, we contacted our participants who play an active role 
in immunization activities at different health care delivery levels. Regional Level: 
multi-lateral agency representatives including WHO, ACDC, and IVI. On the 
National Level, we selected: Government Officials (MOH), Routine immunization 
directors, and Immunization Program Officers. With support from IVI research 
Staff, we identified further participants in the representing countries. On the state 
and local level: Doctors, Epidemiologists, Health care workers, health educators, 
and some Parents were interviewed from the selected countries. Additionally, some 
parents were interviewed for their perceptions about vaccinating their children 
during the current pandemic. 4 participants were interviewed/questionnaire from 
each country; in total 20 participants were included in the study.  (Table 2.1) 
 DRC Uganda Egypt Moz. Nigeria Total 
Regional Level:  
Researchers (IVI, WHO)   1  1 1 3 
National Level:  
National vaccination officers  1 1  1 3 
State:  
Routine immunization directors 1     1 
Epidemiological surveillance and 
Mass Vaccination supervisors 
1   1  2 
EPI Officers (WHO)  1  1  2 
Local  
Health Care Workers/ 
Caregivers 
2 1 2 1 2 9 
Total: 4 4 4 4 4 20 
Table 2.1: List of Stakeholders interviewed 
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2.5 DATA ANALYSIS 
Using a 4 steps thematic framework analysis approach [44], (Fig. 2.2)  A close reading 
of the data revealed vital categories of events and processes that summarized segments 
of the data, which were then categorized under main themes: country name, covid-19 
situation, the impact of previous disease outbreaks and the impact of covid-19 on the 
subcategories factors (health system, community, and governance). Reading through 
and coding all the transcripts and reviewing the segments revealed consistencies and 
variations in public health conditions, events, and processes that affected immunization 
coverage and public health responses. This process identified and confirmed the most 
significant findings. Assessing situations within countries were then compared and 
assessed with the findings across the countries’ research sites. This process led to 
further identification and confirmation of core issues and analytical themes. 
Quantitative trend data over on childhood rates of measles and immunization coverage 
further illuminated the key informants’ findings.  This triangulation of qualitative data 
within and across countries and the quantitative rates of measles and immunization 
















Provide index and codes to
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applied on the answers









were merged under each
central theme. to start
mapping and interpreting
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3.1.1 The Democratic Republic of Congo: 
i. The current situation of Covid-19 pandemic 
By 27th November 2020, 55 new cases were reported, in total 12,365 cumulative 
cases (0.85 % of all the region cases). The attack rate of 13.15 per 100 000 
population. 331 cumulative deaths with a CFR of 2.68%. 11,433 cumulative 
recovered (92.46% of cumulative cases). 600 active cases with prejudices, rumors, 
and false information circulating about the virus in the capital since declaring the 
first case. [45] 
ii. The impact of covid-19 on the routine immunization activities 
a. On the health system 
On 15th Feb 2020, the first covid-19 case was imported from Europe to the capital 
city Kinshasa. Covid-19 is not the only outbreak of which DRC is struggling with 
recently. Since January 2019, over 6,500 children have died from measles, 
recording 335,000 infections. Over the past 18 months, DRC has responded to the 
second-worst Ebola epidemic in history with 3,453 cases and 2,273 deaths with an 
ongoing cholera outbreak. Considering the DRC’s weakened healthcare system, 
responding to covid-19 was an additional burden to the country that could not 
afford it. Covid-19 did not only affect the routine immunization activities but also 
affected the surveillance and response to the other outbreaks.  
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b. On the community  
Routine immunization activities and measles vaccination campaigns were slightly 
affected by the misinformation. People were afraid that the country could be used 
as a laboratory for a covid-19 vaccine trial. In which people may get injected with 
a dangerous trial vaccine instead of the proven ones. People mistrust of health 
system. “They saw covid-19 is a business from westerners,” said the immunization 
officer in Kinshasa. 
In Kinshasa, between March and April 2020, the average number of children going 
to the health facilities for immunization dropped by 10%. The misinformation 
increased parents’ hesitancy and refusal to vaccinate their children by the Extended 
Program on Immunization (EPI). The immunization coverage of all vaccines 
(hepatitis B, DTP3, IPV, and Hemophilus influenza type b) recorded an 8 to 10% 
decline. Coverage of other vaccines like MCV, yellow fever, and rotavirus 
recorded a 1.5 to 4.5 % decline. [46] “Due to poor communication and 
misunderstanding of a certain portion of the population, some families refused to 
be vaccinated from common routine vaccines thinking that it was against covid-
19”, Said the Routine immunization activities supervisor of 10 health areas of East 
of Kinshasa. 
c. On the governance  
The pandemic response’s biggest challenge was the lack of information, 
infrastructure, funds, and personal protective equipment, besides the limited 
international organization involvement. Responding to the covid-19 was a 
country's responsibility as most of the partners were overwhelmed by responding 
to the pandemic worldwide. 
The government limited the public movement, social gatherings, and advocated for 
mask-wearing and hand hygiene practices. They also provide free access to 
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healthcare for all the population. Implementing those measures has been hard 
because of the logistics challenges, human resources, and rumors that disrupt the 
health system's functioning. A portion of the population even denial covid-19 
existence with no respect for the preventive measures. 
On the other side, the Democratic Republic of Congo (DRC) continues its routine 
immunization activities to tackle measles outbreaks in the North Kivu province, 
east of the country. This outbreak response campaign, launched on 21 April 2020, 
targeting 150,491 children aged 6 months to 5 years in the 7 most-affected health 
zones in North Kivu province. Moreover, the government set up communication 
assistants and health community workers to sensitize community mothers on the 
importance of routine immunization for their children's well-being. 
iii. The impact of previous outbreaks, epidemics, and pandemics on the 
immunization activities. 
From (fig 3.1), we can see that the MCV1 immunization coverage was around 
74% since 2010, which is below the 90% target. This low coverage resulted in 
several measles outbreaks in the following years. In 2012 -2014 Ebola outbreaks 
hit the Democratic Republic of Congo (Appendix 3).  
MCV1 coverage faced a sharp decline in the year 2012, resulting in a second peak 
of the total measles number of cases in 2013. That made the country increase the 
coverage to reach 78% in 2015. 
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Fig. 3.1: The impact of the 2012-2014 Ebola outbreak on the MCV1 
immunization coverage among 1-year-old % in DRC. 
 
MCV2 introduction has another effect on those outbreaks. DRC Could not meet 
the criteria for MCV2 introduction of > 80% coverage of MCV1 at the national 
level for 3 consecutive years. The Ebola Outbreak affected the child health services 
delivery in Eastern Congo. It was found that vaccine uptake was dropped sharply 
during the Ebola period in comparing the vaccine uptake in pre-Ebola and the 
Ebola period. [47] 
During the 2018 Ebola outbreak in DRC, there was a decline in all received 
vaccines compared with the pre-Ebola period (May-July 2018). There was an 
overall decline in the number of children receiving vaccines during the “Ebola 
period” due to a decline in health services use and community perception of 
increased risk of contracting Ebola. Besides the “no-touch” policy. Health care 
workers were ordered not to practice invasive procedures. This contributed to the 
disruption in the immunization provided. The priority was given to the Ebola 
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3.1.2 The Federal Republic of Nigeria: 
i. The current situation of Covid-19 pandemic 
Many socioeconomic factors affect the response to the covid-19 pandemic in 
Nigeria, including the high population density, high poverty, and limited healthcare 
access (Appendix 4). By 27th November 2020, 198 new covid-19 cases were 
reported in Nigeria, 66,805 cumulative cases (4.58 % of all the cases in the region). 
The attack rate of 32.24 per 100 000 population. 1,169 cumulative deaths with a 
CFR of 1.75%. 62,493 cumulative recovered (93.55% of cumulative cases). 3,143 
active cases. Despite the global trend, more young people were affected by the new 
coronavirus in Nigeria than older people. [45] 
ii. The impact of Covid-19 on the routine immunization activities 
a. On the health system  
Although the country's efforts to contain the disease, this pandemic has exposed 
the fragile health system, the inadequate testing capacity, the weak health 
infrastructure, and the sub-optimal health investment and funding challenges in 
Nigeria. The current pandemic indirectly affects the epidemiology of other 
endemic diseases in Nigeria. Like the Lassa fever epidemiological trend that 
indicates the highest case peak reported in 2020. It also affects the response to 
malaria, cholera, measles, yellow fever, and cerebrospinal meningitis outbreaks 
through the limited resource allocation and the inadequate national public health 
working capacity. Due to Covid-19, these supplemental immunization activities in 
Nigeria that achieved 65-73 % improvement in the routine immunization coverage 
by 2019 were pushed back from its 2020 targets. Most of the routine immunization 
activities are carried out in primary health care centers. In the early stages of the 
pandemic, the primary health care centers were closed, and the routine 
immunization activities were temporary suspended over the country. 
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b. On the community 
People's perception of immunization is on change. Hesitancy, traditional, religious, 
and cultural misconceptions are significant issues in Nigeria. People look with 
suspicions about the vaccine. They find it not safe instead it is harmful, especially 
in the northern part. They believe it is another means of reducing their population. 
People trust and community outreach is becoming increasingly difficult during the 
pandemic. There had been a worrying decline in client attendance at health 
facilities in Kano province due to lack of awareness of continued routine 
immunization, as well as fear of COVID-19 infection. Some health care workers 
were also afraid to go to work as a few of their colleagues tested positive for the 
virus.  
c. On the governance 
Nigeria has recently improved in implementing routine immunization activities 
and Supplemental Immunization Activities (SIA). However, it was recorded that 
more than 3 million children under 1-year-old remain unvaccinated in the country. 
Inadequate access to health care, Vaccine hesitancy, and vaccine administration 
fees were the barriers behind getting the children fully immunized. Over the last 
year, the country made efforts to reach every vulnerable child through the 
emergency coordination centers that help reach the target population through 
house-to-house immunization visits to the hard-to-reach communities. The ban on 
movement also prevents the parents from taking their children to immunization. 
iii. The impact of previous disease outbreaks and epidemics on routine 
immunization activities. 
The decline in the MCV1 coverage since 2010 resulted in a series of outbreaks in 
the following year. In 2012 Lassa fever hit the country. The same year, Nigeria 
witnessed the lowest MCV1 coverage reaching 42%. Another slight decline was 
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recorded from 2014-2015, while the country was fighting Ebola and cholera. (Fig 
3.2) 
 
Fig. 3.2: The impact of 2012, Lassa fever, and 2014 Ebola outbreaks on the 
MCV1 immunization coverage among 1years old% in Nigeria. 
 
3.1.3 The Republic of Uganda: 
i. The current situation of Covid-19 pandemic 
As of 27th November 2020, 484 new cases were reported in Uganda, 18,890 
cumulative cases (1.29 % of all the region cases). The attack rate of 38,51 per 100 
000 population’s new reported death, 191 cumulative deaths with a CFR of 1.01%. 
8,832 cumulative recovered (46.75% of cumulative cases) and 9,867 active 
cases.[45] 
ii. The impact of Covid-19 on the routine immunization activities 
a. On the health system  
Covid-19 has affected most of the essential activities, including vaccination in 
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disabled the health workers from moving to their workplace after public transport 
was banned. Nurses were afraid to interact with the people in such a pandemic 
situation. 1.5 million school-going children have missed the Human 
Papillomavirus vaccine due to lockdown and school closure.  
b. On the community 
Most of the confirmed covid-19 cases were in Kampala a with a population 
growth of 1,507,080 people. Urban areas in Uganda have low immunization 
coverage in comparison to the rural areas, and that disrupts the 
immunization activities even more as a hesitance by the community to 
access the facilities during an outbreak of a fear to get infected. 
c. On the governance 
The Ministry of Health successfully contained the disease following the WHO and 
other international organizations’ instructions in response to this pandemic. 
Moreover, early detection of cases and response measures with proper health 
hygiene mask-wearing and social distancing. The Ministry distributed around 
13,455,657 masks and tested about 381749 suspected cases as part of its response 
to the pandemic.  
Uganda was lucky in the current situation since they had a stock of the PPE and 
masks due to their fight against the imported Ebola cases coming from DRC. Due 
to this support from WHO and others, Uganda was able to contain the covid-19 
Pandemic. Moreover, UNICEF supported health workers in the country by 12,000 
pieces of PPE and (chlorine, hand washing soaps, and sanitizers) were supplied to 
the health facilities. On the other side, before the pandemic, Uganda prepared stock 
of its routine vaccines, which facilitate conducting its immunization activities 
although the global lockdown.  




iii. The impact of previous disease outbreaks and epidemics on routine 
immunization activities. 
The total Measles number of cases in Uganda has increased to record a peak of 
more than 8000 cases in the year 2013 (Appendix 3). While Measles containing 
vaccine first dose (MCV1) immunization coverage among 1 – years old (%) were 
progressively increased to decline again by 2014 (Fig. 3.3).  In 2013, many measles 
cases were attributed to immunization coverage level; it was below the target level 
of 95%. With the catchup campaign in 2015, Uganda succeeds in increasing the 
coverage. 
 2014, Uganda was suffering from Marburg hemorrhagic fever. The MCV1 
immunization coverage started to decline in the same year. (Fig.3.3) Recalling the 
Ebola outbreak in 2019 caused a 1- or 2-month disruption in the immunization 
activities. While the country was trying to contain the disease, the health workers 
were running out from the facilities, and the community refused to access the health 
facilities to seek the service. The same factors were behind the 2010 immunization 
disruption during the yellow fever outbreak. People fear to go to the facility, and 
health workers were afraid to go to the community. 
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Fig. 3.3: 2014 Marburg hemorrhagic fever outbreak impact on the MCV1 
immunization coverage among 1-year-old % in Uganda.  
 
3.1.4 The Republic of Mozambique 
i. The current situation of the Covid-19 pandemic. 
As of 27th November 2020, 71 new cases were reported in Mozambique, 15,302 
cumulative cases (1.05 % of all the region cases). The attack rate of 47.82 per 100 
000 population. 1 new reported death, 128 cumulative death with a CFR of 0.84%. 
13,459 cumulative recovered (87.96% of cumulative cases) and 1,715 active cases.  
 
ii. The impact of Covid-19 pandemic on immunization activities. 
a. On the health System 
The capital, Maputo, and Cabo Delgado province are the epicenters of the outbreak 
in the country. Over the past year, more than 162,000 people in Cabo Delgado have 
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are living in overcrowded conditions in host communities. This has left at least 2.5 
million people in urgent need of humanitarian assistance across the country. 
People’s socioeconomic status is inferior, with 50 percent of the population living 
more than 20 kilometers from the nearest health facility (Appendix 4).  
Priority was given to limited resources to the recent pandemic.[48] Routine 
immunization coverage was decreasing, putting Mozambique at risk of outbreaks 
of semi contagious diseases like measles. The significant disruption was addressed 
in the outreach sessions to the remote area where 33 % of children live over 30 
minutes away from the nearest health facility. The maternal and child survival 
program (MCSP) in Mozambique uses reaching every district/reaching every child 
(RED/REC) strategy at health facility levels and in communities to improve 
immunization rates. Due to covid-19, this service was disrupted, and the outreach 
sessions were canceled. Immunization staff and surveillance workers were 
redeployed for the response of covid-19. IPV (polio vaccines), Rota, and DTP; 
reached the buffer stock. Vaccine stock limitation with the global travel ban was 
another big issue in Mozambique. 
b. On the community 
Although the government tried to follow the international guidelines in response 
to the pandemic, most people do not follow these control measures. Markets, 
beaches, and public places are still overcrowded. However, more than 10.000 
people lost their work in 1 week due to those measures. People who survive covid-
19 will die due to socio-economic constraints in Mozambique. Vaccine hesitancy 
is very limited in Mozambique since people are aware of vaccination’s importance 
to their children's health. This public knowledge came from the government efforts 
in community engagement by implementing the Agent Polyvalent Element 
program (APE’s).   
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c. On the governance 
Since the first Covid19 case was reported in March 2020, the supply chain areas 
were the most affected, including the port, airport handling, and warehousing 
sectors. The government issue some measures to control the virus transmission like 
(school closure, suspension of public gatherings, and tightening border controls. 
However, border control was not strict, as many covid19 cases were crossing the 
border with South Africa. The disease prevalence was more than reported due to 
limited testing capacity, reagents, and PPE shortage in all provinces. Most of the 
Covid19 cases were asymptomatic, and less than 200 cases are hospitalized.  
The routine immunization program shows a constant decline of 30 percent in 
immunization coverage for MCV2 and the third dose of DTP. There was a 
reduction in demand due to the temporary disruption of the service. The movement 
restrictions affect a huge workforce employed by the sector of vaccination. [49] 
When the emergency state was elevated, people were advised not to go out, not to 
hospitals, and some vaccine consultations were canceled. Cabo Delgado city 
recorded the highest decline between March and April 2020. Reduction in access 
to the routine immunization activities was witnessed as people were afraid to visit 
the primary health centers for vaccination. It was recorded that 42 out of 126 health 
facilities are non-functional in at least eight districts. 
iii. The impact of previous disease outbreaks and epidemic on the routine 
immunization activities: 
Before Covid-19, multiple disease outbreaks—including cholera and malaria—
were already stretching Mozambique’s weak health systems, and health centers 
were damaged during the cyclones Idai and Kenneth. Internal Displaced People 
)IDPs) in Cabo Delgado face significant challenges in accessing primary health 
care.[50]  
- 29 - 
 
Total measles number of cases sharply increased in 2010 to decrease after the 
country’s mass vaccination campaign in 2011. While the introduction of vaccine 
first dose (MCV1) immunization coverage among 1 – years old (%) has been 
progressively elevated starting 2012 to reach 85% coverage in 2013 (Fig. 3.4). In 
2012 Mozambique implemented an innovation to the vaccine distribution system. 
They optimized vaccine transportation, recasting some roles and responsibilities, 
and increased data visibility. This new approach was behind the progressive 
increase in immunization coverage in the country. The cholera outbreak in Cabo 
Delgado and Nampula provinces reported 1,000 cases and 17 deaths to date. In 
response to this outbreak, the country was supported by vaccine and equipment 
stock before the lockdown of the country of Covid19 pandemic. (Fig.3.4) Cholera's 
impact on the routine immunization activities was not significant. The 
immunization staff was not involved in the cholera response. They were not 
required to provide the cholera vaccination. The community health worker was 
trained to provide the service not to disrupt the routine immunization service.  
 
    Fig. 3.4: 2018 Cholera outbreak impact on the MCV1 immunization coverage 
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However, a circulating vaccine-derived poliovirus type 2 (cVDPV2) affected 
Mozambique's routine immunization system in 2019 (Appendix 3) in the Molumbo 
district, Zambézia. The government had to deploy as much as possible health staff 
from all over the country to support the immunization campaign. Financial, human 
and material resources were deployed for polio.  
3.1.5 The Arab Republic of Egypt: 
i. The current situation of Covid-19 pandemic 
Since the announcement of the first case of the SARS-CoV-2 on February 14, 
2020, in Egypt, the government started multidisciplinary national coordination 
between different ministries and international organizations like WHO. As of 27th 
November 2020, 368 new Covid-19 cases were reported, 114,475 cumulative 
cases. 11 new reported death, 6,596 cumulative death with a CFR of 5.7%. 
102,268 cumulative recovered (89.33% of cumulative cases). [51] 
ii. The impact of Covid-19 pandemic on the routine immunization 
activities: 
a. On the health system 
As a primary response strategy to Covid19, the Ministry of Health was forced to 
change the traditional confrontation with the epidemic. Instead of hospitals being 
the first frontline for the disease, the health unit or health office located in every 
neighborhood or village is the first to deal with the disease. That decreased the 
burden on the referral hospitals and staff. Moreover, the Ministry opened the door 
to volunteering. Graduates of science, veterinary medicine, pharmacists, and 
dentistry were given a chance to play complementary roles in isolation and referral 
hospitals or with field investigation and follow-up teams. 
The new strategy in response to covid-19 was a two-sided coin. Health units and 
primary health care centers are mandated to provide routine immunization 
activities in all governorates. The units’ immunization service did not face much 
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disruption, like the nurses who provide vaccination were available to provide the 
service all the time. Vaccine stock and supply chain of the mandatory vaccination 
did not face any disruption in Egypt.  
b. On the community 
Fear of infection has escalated within the society about their children's safety while 
receiving the routine immunization services in the health units. Our research found 
that 60% of the responded parents were afraid of catching a covid-19 infection 
while visiting the health facilities. This fear was due to crowds in the health facility 
rather than being afraid of the vaccine itself. However, this did not stop the parents 
from going to the health facilities to vaccinate their children through the routine 
schedule.  
Although their concerns, people were afraid that the delay in vaccinating their 
children due to the new coronavirus outbreak will have adverse effects on their 
future health. 95% of the responded parents vaccinated their children according to 
their routine immunization schedule without any delay. 100% were taking the 
safety measures of wearing the mask while receiving the services, and 95% agreed 
that immunization on time is vital for their children's health. 
c. On the governance 
In response to the current situation, the government followed the global guidelines 
of banning air flights, applying temporary country lockdown, and social distancing 
measures in crowded places. The government provided the health workers with the 
proper PPE and distributed 40 million fabric masks on the population ration cards 
system in all governorates. 
The government increased media awareness about the importance of receiving 
routine immunization on time. Moreover, The MOH launched a new national 
campaign to vaccinate against polio, targeting those born between January 1, 2016, 
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until March 22, 2018. They put some strict measures during the campaign (only 
one person to be with the child to prevent overcrowding, wear musk and use hand 
sanitizer), noting that vaccinations are available in all health offices. This campaign 
targeted polio vaccination for 6 million children, and foreign children were also 
included. 
iii. The impact of previous disease outbreaks and epidemics on the 
immunization activities. 
In 2015, Egypt reported an outbreak of dengue fever. There was an increase in the 
total number of measles cases to above 5000, and the immunization coverage was 
declined from the year before to a record 92% (Fig 3.5). 
 
Fig. 3.5: 2015, Dengue fever outbreak impact on the MCV1 immunization 
coverage among 1-year-old % in Egypt. 
 
In response to the 2015 measles outbreak, the health authorities in Egypt in 
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in the period from October to November of the same year. [52] 24 million children 
aged 9 months to 10 years were vaccinated in this campaign all over the Egyptian 
governorates in health care facilities, schools, and nurseries [52]. Since then, Egypt 
strengthens its immunization communication system to ensure that children 
targeted for vaccination are reached. That came in parallel to the national 
immunization campaigns that target the missed opportunities with vaccine 
promotion campaigns.  
Summary 
In summarizing our findings, 40% of our participants emphasized that fear of 
infection was behind the interruption in the immunization activities during the 
Covid19 pandemic. In contrast, 35% agreed that movement restrictions limited 
many activities. Resource limitation and misinformation became an individual 







Fig. 3.6: Participants' response to the main factors affected the routine 
immunization activities during the covid-19 pandemic. 
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Between 2013-2016 the Ebola outbreak affected the routine immunization 
coverage in the region when most of the resources were allocated to support the 
Ebola response. The response strategy to the outbreak affected the immunization 
coverage leading to many measles outbreaks and other vaccine-preventable 
diseases. Covid-19 pandemic has a similar impact though with wider dimensions 
and magnitude due to its broad distribution, high infectivity, the burden on public 
health systems to mitigate and contain it, and its impact on social functioning in 
general, and the precautions and resistances of health care workers and families to 
participate in health systems. 
Table (4.1) tried to address the thematic factors that may affect the routine 
immunization activities during a disease outbreak. Those main factors were 
supported by findings from the previous Ebola outbreak and the recent covid19 
pandemic. In comparing the factors, we tried to conclude interventions for future 
disease x that may impact the routine immunization services.   
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Table 4.1 lessons learned, where immunization activities need to be strengthened with disease outbreaks/ pandemics. 
Challenges  Factors disrupting the routine 
immunization service during previous 
outbreaks. 
Factors disrupting the routine 
immunization service during the 
Covid-19 pandemic. 
Some interventions to support immunization 
activities during Disease x outbreak  
Health System  Reduced health services 
Priority was given to Ebola cases 
response; the EVD outbreak disrupted 
health care systems in the region, 
weakened the local health care system, 
and increased the number of susceptible 
children 
 
The shortage of health workforce In 
east Africa, the ‘no-touch’ policy 
affected the service delivery as HCW 
were ordered not to conduct invasive 
services. All planned national 
immunization campaigns were 
postponed due to human resource 
limitations. 
 
Damaged infrastructures  
Telecommunications, logistics 
transportation, and supply chain were 
very disrupted. Surveillance, outreach 
sessions, and campaigns were all 
suspended.  
Shortage of safety equipment’s 
Many countries could not provide 
the PPE to the health worker who 
provides vaccines due to resource 
limitations. 
 
Limited human resources 
HCW for vaccination service was 
unavailable because of movement 
restrictions or being redeployed to 
outbreak response duties. 
 
Vaccine logistics and supply 
chain 
were disrupted due to a travel ban 
and movement restriction. 
 
 
Health service should be maintained and 
safeguarded during any disease outbreak  
 
Ensure vaccine stockpiling and equipment 
availability (syringe, masks, gloves, and PPE). 
Countries may advocate for the local production of 
the medical equipment. Regional companies can 
produce the PPE requirements to be used during 
vaccination that would offer a good solution in the 
case of a lockdown. 
 
Capacity building. Increase health care workers' 
knowledge and motivation. 
 
Engage partners and donors to ensure the supply 
chain to function well. 
 
Free healthcare services may result in increased use 
of services. 
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Community Fear of disease transmission 
Information and awareness were 
minimal with no communication and 
protective measures that can decrease 
people's fear. 
 
Rumors and Misinformation 
affected people's trust in their 
government in response to the outbreak. 
 
Vaccine hesitancy and refusal 
Community resistance to vaccination, 
hesitancy about its effectiveness in 
comparison to natural disease immunity. 
 
Culture and beliefs  
The high population density, the high 
birth rate, and the poor access to 
vaccination aligned with a high 
incidence of epidemics. 
 
Lack of Community awareness with 




Fear of disease transmission  
People were afraid of being 
exposed to the disease. Whether in 
the community or the health care 
facilities. 
 
Rumors and Misinformation  
People mistrust their government; 
they were afraid that the country 
could be used as a laboratory for 
Covid19 vaccine trials. 
 
 
Vaccine hesitancy and refusal  
People's misconception of vaccine 
safety was addressed. They were 
not able to access the services. 
People trust and community 
outreach is becoming increasingly 
difficult during the outbreaks. 
Provide social listening tools to collect data (online 
and offline) 
Social network analysis and media monitoring. 
Media may influence in decreasing vaccine 
confidences and acceptance, fabrication and sketchy 
reports of so-called vaccine reactions and anti-
vaccination campaigns influence in parent hesitancy 
about vaccination 
Social inoculation, community sensitization, and 
engagement with influencers and stakeholders in 
society can amplify and concrete messages to their 
constituents. (e.g, religious and youth organizations) 
Rumors tracking and fact-checking health-related 
claims and debunking, countering, and correcting 
false claims 
Increase people's knowledge, attitude, and 
practice of Non- pharmaceutical intervention.   
Infodemic management, support evidence 
synthesis, and science communication  
Use of technology tools to disseminate messages 
(hotline, website app Chatbots, SMS, etc.) 
Provide event-based digital surveillance of 
infodemic and misinformation. 
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Governance People movement across porous 
borders 
Displaced and refugees who missed the 
vaccination in their country increased 
the governments’ burden and affected 
the immunization coverage. 
 
Political commitment 
Some leaders demonstrated little interest 
in building laboratories and hospital 
capacity and better working conditions 
for conducting immunization activities. 
 
Financial burden 




Countries affected by conflict suffer 
from; damaged infrastructure, exhausted 
human resources, limited vaccine 
accessibility, and availability that delay 
the vaccine's introduction and campaign 
implementation. 
Closing the primary health care 
center: primary health care 
centers were closed as part of the 
government measures to limit 
public gathering. 
 
Movement and Public transport 
restriction. 
Because of movement restriction, 
people were unable to visit the 
health facilities. Furthermore, a 
house to house visits in the rural 
areas was disrupted. 
 
Country Lockdown affected 
vaccine supply chain and stock in 
some countries  
 
Governments should set new policies to ensure that 
essential services maintain functioned under any 
circumference. 
 
Proper strategic planning for any emerging disease 
outbreak with budget allocation may help to decrease 
the financial burden. 
 
Sharing experiences can help improve other 
countries' strategies.  
 
Engage partners to support the outbreak response 
and safeguard the immunization services. 
 
Afford ways to bring the vulnerable communities to 
health facilities and provide the health workers with 
the proper training on how to deal with such a 
situation to contact the community. 
 
Implement a proper registry system for refugees 
and displaced persons indicating the immunization 
situation. 
 




In 2019, many African children missed out on life-saving vaccines. They were 
likely to lack access to the health service itself. Most of those children were 
concentrated in the Democratic Republic of the Congo and Nigeria. The places 
where disease outbreaks were one of the reasons to miss vaccine-preventable 
disease immunization. The immunization of children against various diseases has 
significantly decreased since the outbreak of the Covid-19 compared to last year, 
as many children around Africa are now unprotected from diseases.  
Our study addressed that the reasons for the disrupted immunization services vary 
according to each country's situation, preparedness, and response strategy to each 
outbreak or pandemic. Even when services are offered, people cannot either access 
them because of caution to leave home, transport interruptions, movement 
restriction, or fear of being exposed to the disease.  
However, during an outbreak, the interruption happened when the health facilities 
are overwhelmed by responding to the disease rather than promoting health or 
caring for primary health services like immunization. Many of the health care 
workers were redeployed in response to the outbreak. People were more concerned 
about the patients in the community rather than taking healthy children to 
immunization.  
The misinformation increased parents’ hesitancy and refusal to vaccinate their 
children by the Extended Program on Immunization (EPI). In DRC people were 
afraid that the country could be used as a laboratory for a COVID-19 vaccine trial. 
To overcome any immunization gap during the Covid19 pandemic, DRC continued 
its routine immunization activities with some modifications, including (social 
distancing measures and limiting the health care facility visitors). Health workers 
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who provide the vaccine were equipped with the proper PPE provided by UNICEF, 
and the public was advised to wear masks and practice hand hygiene measures. 
[53] This came in parallel to the measles response campaign targeting children 
aged 6 months to 5 years in the country’s most affected areas with the same 
modifications to limit the COVID-19 transmission. The global response measures 
to COVID-19 affected public transportation and disrupted the vaccine logistics and 
supply chain. Vaccine stockpiling and equipment (Syringe, masks, gloves, and 
PPE) were limited during the global lockdown, especially in a landlocked country 
like Mozambique.  
Moreover, COVID-19 did not only affect the routine immunization activities but 
also affected the response to the other outbreak. Immunization staff and 
Surveillance workers were redeployed for the response of COVID-19. This affects 
the indicators tracking for other suspected disease outbreaks. While the health 
facilities have been recorded as another big challenge due to the pandemic and 
lockdown in Nigeria. In the early stages of the pandemic, the primary health care 
centers closed, and the routine immunization activities were temporary suspended 
over the country. People's trust and community outreach became increasingly 
difficult during the pandemic.  
The movement restriction disabled people from accessing health services and 
disabled the health worker's movement to their workplace. Nurses and vaccine 
providers were afraid to interact with the people in such a pandemic situation. In 
Uganda, school closures resulted in missed opportunities for the Human 
Papillomavirus vaccine by 1.5 million school-going children. In the same context, 
Fears have escalated within the Egyptian society about their children's safety while 
receiving the routine immunization services in the health units. However, people 
were afraid that the delay in vaccinating their children due to the pandemic, will 
negatively affect their future health. 
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In response to the current situation of the COVID-19 pandemic, the World Health 
Organization recommended that every country conduct an individual benefit-risk 
assessment. This report shall assist the decision-makers’ ability to sustain the 
immunization activities during the pandemic based on the local transmission, the 
health system capacity, and the epidemiology of vaccine-preventable diseases. 
This kind of assessment shall predict the impact of COVID-19 on the routine 
immunization coverage in the region. Moreover, early this year, WHO and the Pan 
American Health Organization issued a guideline on the routine immunization 
activities during the COVID-19 pandemic.[54] Routine immunization activities 
were advised to be conducted in place while maintaining social distancing 
measures. However, many African counties lack adequately trained human 
resources and protective equipment to conduct the activities under such conditions. 
The death prevented by sustaining routine childhood immunization in Africa 
outweighs the excess risk of COVID-19 death. Routine childhood immunization 
should be sustained in Africa as much as possible, considering other factors such 
as logistical constraints, staff shortages, and reallocation of resources during the 
pandemic.[55]Vaccine refusal has been associated with outbreaks of many 
diseases in many African countries. Vaccine hesitancy is becoming a more 
significant issue. Usually, it comes when introducing new vaccines and campaigns 
under the routine vaccine. It has been attached to the community and households 
because of their beliefs, and they recruit more people around the countries, not only 
in a specific area. During the HPV campaign for the 10-year-old girls in Uganda, 
some communities raise rumors that the vaccine causes infertility. That’s why 
attached to girls, it also causes cancer.  Outbreaks of polio were reported in 
Northern Nigeria due to vaccine refusal, and recently some communities in Nigeria 
encourage people to refuse their children's vaccination. People believe that 
vaccines are away from the government to reduce their population. Social, multi-
ethnic, demographic, psychosocial, and multireligious factors with diverse cultural 
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beliefs were behind Nigeria’s vaccine hesitancy. Further studies and interventions 
are needed to control this community's attitude before the problem gets bigger in 
Africa. Immunization act to punish people who encourage those ideas were 
advocated in many African countries. However, this may affect people's perception 
of vaccination and their trust in the government.  
“Heavy rain caused flooding in Kasese district in Uganda early this year, and it 
called for resources. Without the external support from the Red Cross, they would 
have affected all the facilities in the district,” Said the National Immunization 
Officer – Uganda. Planning for immunization in a humanitarian disaster can 
decrease the impact of such disasters on the immunization coverage. As witnessed 
during the current COVID-19 pandemic, most international organizations 
reallocated all its resources to respond to the pandemic. Hence, it is the country's 
responsibility for proper strategic planning in such a crisis. Disaster planning may 
save lives and prevent disease outbreaks. 
“Last year, Uganda discovered they are not producing enough vaccines, including 
measles. They had a fixed budget of 20 billion Ugandan shillings have been used 
for the last 10 years also. So, from 2010 if the budget for the vaccine is the same 
in 2019, then they are buying vaccines for the same amount to population growth. 
Somewhat the ministry of health and finance is not communicating to work out the 
mechanism of improving the financing of the vaccine to the population growth. 1.5 
million children annually need to be matched with the resources.” Said the EPI 
officer, WHO- Uganda. Many factors are beyond the financial barriers to 
immunization in Africa. Besides providing the vaccine, Gavi support enables many 
African countries to address some of the critical barriers by supporting the health 
system and providing logistic support. However, it cannot meet all the demands. It 
should be from the government side to fill the other parts, but they still have 
financial constraints to fill the gap. 
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4.1 Recommendations: 
COVID-19 is not the first and may not be the last pandemic. Countries should be 
equipped almost all the time with the essential equipment, adequate vaccine doses 
as a stock for emergencies. The governments need to have national planning for 
disasters and disease outbreaks; otherwise, we will always be going through such 
disease burdens. In overcoming the disruption that affects the immunization 
activities, the recovery should be speedy to avoid any long-term impacts. We 
addressed some interventions to support immunization activities during the 
Disease x outbreak (Table 4.1) as lessons learned from COVID-19. However, a 
Proper register system of all benefits in disasters is needed to Track who was 
immunized, who needs an immunization, and who has missed. To improve the 
performance as people are on the move over time.  
There remain many opportunities to increase coverage. Community engagement 
can be enhanced to improve coverage through orientation/sensitization of 
community leaders and influencers on the importance of engaging caregivers and 
following up with those who default. Routine immunization activities should be 
safeguarded as much as is logistically possible, for continued service delivery, as 
part of the response to any disease outbreak in Africa.     




In conclusion, infectious disease outbreaks, epidemics, and pandemics affect 
routine immunization and health services. The factors related to the impact of the 
COVID-19 pandemic were corroborated by the burden on public health systems 
and the delivery of routine immunizations that occur to varying degrees in disease 
outbreaks, epidemics, and pandemics. The study addressed different factors that 
may pose barriers to immunization during any future disease x outbreak, or 
epidemic. The impact of the COVID-19 pandemic has a similar impact, though 
with wider dimensions and magnitude. The impact of COVID-19 was due to its 
broad distribution, high infectivity, it’s a burden on the public health systems, and 
the precautions and resistances that have been taken to mitigate it. 
Disrupting the immunization coverage in Africa could be a revival of many 
vaccine-preventable diseases. Responding to any disease outbreak should be 
coupled with the strengthening of the routine immunization services to mitigate the 
risk. 
STUDY LIMITATIONS 
1. The study does not represent all of Africa’s situation since we are doing it in only 
5 countries with only 20 participants. Non-sample error; as the interviews were 
conducted online, internet connection and time zone differences were a big 
challenge.  
2. Language differences were another challenge. For DRC and Egypt representatives, 
we had to translate the interview questions and share them by email. We received 
their correspondence in the same way. Away that may have some transcription 
differences.  However, follow up questions were sent for more information and 
clarification. 
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APPENDIX 
Appendix 1: Measles Containing vaccine First dose (MCV1) immunization 
coverage among 1 – years old (%) (2010-2018) 
Year Nigeria DRC 
Congo 
Egypt Uganda Mozambique 
2010 56 74 96 73 82 
2011 49 74 96 75 82 
2012 42 72 93 80 82 
2013 42 76 96 83 85 
2014 44 77 93 85 85 
2015 43 79 92 79 85 
2016 65 77 95 79 85 
2017 65 80 94 79 85 




Appendix 2: Total Measles number of cases from (2010-2018). 
Year Nigeria DRC Congo Egypt Uganda Mozambique 
2018 7063 69693 48 2627 16 
2017 11190 45107 24 1021 122 
2016 17136 5092 225 139 NA 
2015 12423 5020 5432 478 79 
2014 6855 33711 1314 314 9 
2013 52852 88381 405 7878 8 
2012 6447 72029 245 2027 145 
2011 18843 133802 26 3312 177 
2010 8491 5407 16 1313 2321 
2012 60 70 86 85 83 
2011 60 70 86 85 83 
2010 69 77 86 85 83 
https://www.who.int/data/gho/data/indicators/indicator-details/GHO/measles---
number-of-reported-cases [57] 
- 45 - 
 
Appendix 3: Infectious disease outbreaks from (2010 – 2020). 
year Nigeria DRC Congo Egypt Uganda Mozambique 
2020 Lassa fever, 
Covid 19  
Ebola, 
Covid19 
Covid19 Yellow Fever, 
Covid19 
 




 Ebola  cVDPV2 






 Typhoid fever Cholera 
2017 Yellow fever, 
Monkeypox, 
Cholera, Acute 








2016 Wild and 
cVDPV2, Lassa 
fever 
Yellow fever  Yellow fever  
2015 meningococcal Cholera Dengue fever Typhoid fever  
















2011  Cholera    
2010  Yellow fever    
https://www.afro.who.int/ [58] 
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Appendix 4: Socioeconomic Indicators (2018- 2019 estimates) 
Country Nigeria DRC Egypt Uganda Moza
mbiq
ue 








Population under age 5 (millions) 32.9 15.2 13.0 7.5 4.9 
Mortality rate, infant (per 1,000 
live births) 
64.6 701 18.8 35.4 53.3 
Mortality rate, under-five (per 
1,000 live births) 
100.2 91.1 22.1 
 
49.0 72.4 
GNI per capita, PPP (current 
international $) (2018) 
5,040 
 
1,070 11,350 1,780 1,290 
Gross national income (GNI) per 
capita (2011 PPP $) 
5,086 800 10, 1,752 1,154 




27 122 161 
http://hdr.undp.org/en/countries [59] 
 
Appendix 5: Interview Questions 
 Introduction  Welcoming remarks  
Study Brief 
A. The situation of the country 
 On the current 
situation of a covid-
19 pandemic: 
 
How many cases are detected in the country?  
What are the measures taken by the country in response to Covid19?  
Do you think the country faces challenges testing and containing this 




Please tell us about the nature of your work in the country.  
Can you elaborate on your role regarding immunization?  
What is the impact of a covid-19 pandemic on the existing 
immunization activities in the country? 
C. Impact of 
outbreaks, 
Do you believe that (country) is well prepared to deal with disease 
outbreaks like this?  




What was the impact of these outbreaks on vaccination coverage? 
And how the country deal with those challenges? 
D. Vaccine hesitancy 
 
How can you define vaccine hesitancy or refusal in (Country Name)? 
Does this increase during outbreaks? Do you think Public information 
and communications can solve this hesitancy problem? Please 
elaborate 
E. Other barriers 
 
Have you faced other challenges conducting immunization activities 
in (Country Name)? What are those challenges? 
F. Solutions 
 
What are the proper strategies to limit the impact of the outbreak, 




Do you have other recommendations for future implementation to 
limit those barriers? 
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